Long term steroid use in cancer patients

The illicit anabolic steroid market includes steroids that are not commercially available in the . as well as those which are available. Steroids that are commercially available in the . include fluxoymesterone (Halotestin® ), methyltestosterone, nandrolone (Deca-Durabolin® , Durabolin ® ), oxandrolone (Oxandrin® ), oxymetholone (Anadrol® ), testosterone, and stanozolol (Winstrol® ). Veterinary steroids that are commercially available in the . include boldenone (Equipoise® ), mibolerone, and trenbolone (Revalor® ). Other steroids found on the illicit market that are not approved for use in the . include ethylestrenol, methandriol, methenolone, and methandrostenolone.

About the National Institute on Drug Abuse (NIDA):  The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, . Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at , which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to [email protected] . Online ordering is available at . NIDA’s media guide can be found at /publications/media-guide/dear-journalist , and its easy-to-read website can be found at . You can follow NIDA on Twitter and Facebook .

Long term steroid use in cancer patients

long term steroid use in cancer patients

Media:

long term steroid use in cancer patientslong term steroid use in cancer patientslong term steroid use in cancer patientslong term steroid use in cancer patientslong term steroid use in cancer patients